Loss of ATRX/DAXX Expression and Alternative Lengthening of Telomeres in Uterine Leiomyomas

Cancer - United States
doi 10.1002/cncr.31754
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Alternative Lengthening of Telomeres Phenotype and Loss of ATRX Expression in Sarcomas (Review)

Oncology Letters
Cancer ResearchOncology
2018English

ATRX Loss Induces Multiple Hallmarks of the Alternative Lengthening of Telomeres (ALT) Phenotype in Human Glioma Cell Lines in a Cell Line-Specific Manner

PLoS ONE
Multidisciplinary
2018English

A Glioblastoma Neurosphere Line With Alternative Lengthening of Telomeres

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2013English

Mutant IDH1 Cooperates With ATRX Loss to Drive the Alternative Lengthening of Telomere (ALT) Phenotype in Glioma

Cancer Research
Cancer ResearchOncology
2018English

A Novel Telomere Structure in a Human Alternative Lengthening of Telomeres Cell Line

Cancer Research
Cancer ResearchOncology
2005English

Topoisomerase IIIα Is Required for Normal Proliferation and Telomere Stability in Alternative Lengthening of Telomeres

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2008English

Telomere Dysfunction and Activation of Alternative Lengthening of Telomeres in B-Lymphocytes Infected by Epstein–Barr Virus

Oncogene
Cancer ResearchGeneticsMolecular Biology
2013English

Author Correction: The FANCM-BLM-TOP3A-RMI Complex Suppresses Alternative Lengthening of Telomeres (ALT)

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Relationship Between Mast Cell Subtypes and Cyclooxygenase-2 Expression in Uterine Leiomyomas

Journal of Academic Research in Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy